Poly (I:C) induced immune response in lymphoid tissues involves three sequential waves of type I IFN expression

Virology

Volumn 386, Issue 2, 2009, Pages 225-236

  Démoulins, Thomas ^a   Baron, Marie Laurence ^a   Kettaf, Nadia ^a   Abdallah, Ali ^a   Sharif Askari, Ehssan ^a,c   Sékaly, Rafick Pierre ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Double stranded RNA; IFN heteroduplex tracking assay (IFN HTA); Interferon regulatory factor (IRF); Interferon (IFN ) subtypes

Indexed keywords

ALPHA1 INTERFERON; ALPHA2 INTERFERON; ALPHA4 INTERFERON; ALPHA5 INTERFERON; ALPHA6 INTERFERON; ALPHA6T INTERFERON; ALPHA8 INTERFERON; BETA INTERFERON; INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 7; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; LYMPHOID TISSUE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMUS; UPREGULATION;

MUS;

EID: 62949206258     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.01.024     Document Type: Article

References (50)

1. Anjuere F., Martin P., Ferrero I., Fraga M.L., del Hoyo G.M., Wright N., and Ardavin C. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 93 2 (1999) 590-598
2. Asselin-Paturel C., and Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J. Exp. Med. 202 4 (2005) 461-465
3. Barnes B.J., Moore P.A., and Pitha P.M. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276 26 (2001) 23382-23390
4. Barnes B.J., Field A.E., and Pitha-Rowe P.M. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J. Biol. Chem. 278 19 (2003) 16630-16641
5. Bernardin F., Doukhan L., Longone-Miller A., Champagne P., Sekaly R., and Delwart E. Estimate of the total number of CD8+ clonal expansions in healthy adults using a new DNA heteroduplex-tracking assay for CDR3 repertoire analysis. J. Immunol. Methods 274 1-2 (2003) 159-175
6. Biron C.A. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10 5 (1998) 383-390
7. Biron C.A. Interferons alpha and beta as immune regulators-a new look. Immunity 14 6 (2001) 661-664
8. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5 12 (2004) 1219-1226
9. Démoulins T., Abdallah A., Kettaf N., Gerarduzzi C., Gauchat D., Gratton S., and Sékaly R.-P. Reversible blockade of thymic output: an inherent part of TLR ligands-mediated immune response. J. Immunol. 181 10 (2008) 6757-6769
10. Fung M.C., Sia S.F., Leung K.N., and Mak N.K. Detection of differential expression of mouse interferon-alpha subtypes by polymerase chain reaction using specific primers. J. Immunol. Methods 284 1-2 (2004) 177-186
11. Gessani S., Di Marzio P., Rizza P., Belardelli F., and Baglioni C. Posttranscriptional regulation of interferon mRNA levels in peritoneal macrophages. J. Virol. 65 2 (1991) 989-991
12. Guidotti L.G., and Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19 (2001) 65-91
13. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., and Si-Tahar M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280 7 (2005) 5571-5580
14. Hata N., Sato M., Takaoka A., Asagiri M., Tanaka N., and Taniguchi T. Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus. Biochem. Biophys. Res. Commun. 285 2 (2001) 518-525
15. Hewson C.A., Jardine A., Edwards M.R., Laza-Stanca V., and Johnston S.L. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J. Virol. 79 19 (2005) 12273-12279
16. Hida S., Ogasawara K., Sato K., Abe M., Takayanagi H., Yokochi T., Sato T., Hirose S., Shirai T., Taki S., and Taniguchi T. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13 5 (2000) 643-655
17. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., Han J., and Beutler B. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424 6950 (2003) 743-748
18. Honda K., and Taniguchi T. Toll-like receptor signaling and IRF transcription factors. IUBMB Life 58 5-6 (2006) 290-295
19. Honda K., Takaoka A., and Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25 3 (2006) 349-360
20. Hughes Jr. T.K., Chin R., Tyring S.K., and Rady P.L. Distinction of mouse interferon-alpha subtypes by polymerase chain reaction utilizing consensus primers and type-specific oligonucleotide probes. J. Interf. Res. 14 3 (1994) 117-120
21. Kuhara T., Yamauchi K., Tamura Y., and Okamura H. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J. Interferon Cytokine Res. 26 7 (2006) 489-499
22. Le Goffic R., Balloy V., Lagranderie M., Alexopoulou L., Escriou N., Flavell R., Chignard M., and Si-Tahar M. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2 6 (2006) e53
23. Levy D.E., Marie I., Smith E., and Prakash A. Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 22 1 (2002) 87-93
24. Levy D.E., Marie I., and Prakash A. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 15 1 (2003) 52-58
25. Mamane Y., Heylbroeck C., Genin P., Algarte M., Servant M.J., LePage C., DeLuca C., Kwon H., Lin R., and Hiscott J. Interferon regulatory factors: the next generation. Gene 237 1 (1999) 1-14
26. Marie I., Durbin J.E., and Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17 22 (1998) 6660-6669
27. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T.M., Amakawa R., Kishihara K., Wakeham A., et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75 1 (1993) 83-97
28. Montoya M., Schiavoni G., Mattei F., Gresser I., Belardelli F., Borrow P., and Tough D.F. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99 9 (2002) 3263-3271
29. Nickolaus P., and Zawatzky R. Inhibition by interleukin-4 of constitutive beta interferon synthesis in mouse macrophages. J. Virol. 68 10 (1994) 6763-6766
30. Oritani K., Kincade P.W., Zhang C., Tomiyama Y., and Matsuzawa Y. Type I interferons and limitin: a comparison of structures, receptors, and functions. Cytokine Growth Factor Rev. 12 4 (2001) 337-348
31. Prakash A., and Levy D.E. Regulation of IRF7 through cell type-specific protein stability. Biochem. Biophys. Res. Commun. 342 1 (2006) 50-56
32. Rehli M. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23 8 (2002) 375-378
33. Riou C., Yassine-Diab B., Van grevenynghe J., Somogyi R., Greller L.D., Gagnon D., Gimmig S., Wilkinson P., Shi Y., Cameron M.J., Campos-Gonzalez R., Balderas R.S., Kelvin D., Sekaly R.P., and Haddad E.K. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J. Exp. Med. 204 1 (2007) 79-91
34. Rudd B.D., Burstein E., Duckett C.S., Li X., and Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 79 6 (2005) 3350-3357
35. Salio M., and Cerundolo V. Viral immunity: cross-priming with the help of TLR3. Curr. Biol. 15 9 (2005) R336-R339
36. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 4 (2001) 778-809 table of contents
37. Sanghavi S.K., and Reinhart T.A. Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J. Immunol. 175 8 (2005) 5314-5323
38. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., and Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 4 (2000) 539-548
39. Schoenemeyer A., Barnes B.J., Mancl M.E., Latz E., Goutagny N., Pitha P.M., Fitzgerald K.A., and Golenbock D.T. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J. Biol. Chem. 280 17 (2005) 17005-17012
40. Schroder M., and Bowie A.G. TLR3 in antiviral immunity: key player or bystander?. Trends Immunol. 26 9 (2005) 462-468
41. Tailor P., Tamura T., and Ozato K. IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 16 2 (2006) 134-140
42. Tailor P., Tamura T., Kong H.J., Kubota T., Kubota M., Borghi P., Gabriele L., and Ozato K. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 27 2 (2007) 228-239
43. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat. Rev., Immunol. 6 2 (2006) 127-135
44. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S., Honda K., Ohba Y., Mak T.W., and Taniguchi T. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 7030 (2005) 243-249
45. Tanaka N., Sato M., Lamphier M.S., Nozawa H., Oda E., Noguchi S., Schreiber R.D., Tsujimoto Y., and Taniguchi T. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3 1 (1998) 29-37
46. Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19 (2001) 623-655
47. van Pesch V., and Michiels T. Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J. Biol. Chem. 278 47 (2003) 46321-46328
48. van Pesch V., Lanaya H., Renauld J.C., and Michiels T. Characterization of the murine alpha interferon gene family. J. Virol. 78 15 (2004) 8219-8228
49. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., and Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10 12 (2004) 1366-1373
50. Zawatzky R., Wurmbaeck H., Falk W., and Homfeld A. Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages. J. Virol. 65 9 (1991) 4839-4846